Nicola Dusi

Nicola Dusi

Auto-generated profile, based on publicly available information

Nicola Dusi

Psychiatry Unit, Department of Mental Health, ASST-Nord Milano, Milan, Italy

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 August 2015 in Current Neuropharmacology
Verified
Journal Article
Open access
PDF file
NDNicola Dusi
Nicola Dusi
Stefano BarlatiStefano Barlati
Stefano Barlati
AVAntonio Vita
Antonio Vita
Paolo BrambillaPaolo Brambilla
Paolo Brambilla
Depressive disorder is a very frequent and heterogeneous syndrome. Structural imaging techniques offer a useful tool in the comprehension of neurobiological alterations that concern depressive disorder. Altered brain structures in depressive disorder have been particularly located in the prefrontal cortex (medial prefrontal cortex and orbitofrontal cortex, OFC) and medial temporal cortex areas (hippocampus). These brain areas belong to a structural and functional network related to cognitive and emotional processes putatively implicated in depressive symptoms. These volumetric alterations may also represent biological predictors of response to pharmacological treatment. In this context, major findings of magnetic resonance (MR) imaging, in relation to treatment response in depressive disorder, will here be presented and discussed.

17 April 2012 in Acta Psychiatrica Scandinavica
Verified
Journal Article
Closed access
PDF file
Cinzia PerliniCinzia Perlini
Cinzia Perlini
AMAndrea Marini
Andrea Marini
MGMarco Garzitto
Marco Garzitto
MIM. Isola
M. Isola
SCS. Cerruti
S. Cerruti
Paolo BrambillaPaolo Brambilla
Paolo Brambilla

1 July 2014 in Translational Psychiatry
Verified
Journal Article
Open access
PDF file
Paolo BrambillaPaolo Brambilla
Paolo Brambilla
MBMarcella BELLANI
Marcella BELLANI
MIM Isola
M Isola
ABA Bergami
A Bergami
VMV Marinelli
V Marinelli
RFRoberto Furlan
Roberto Furlan
We here present data on immune gene expression of chemokines, chemokine receptors, cytokines and regulatory T-cell (T-reg) markers in chronic patients suffering from either schizophrenia (SCZ, N=20) or bipolar disorder (BD=20) compared with healthy controls (HCs, N=20). We extracted RNA from peripheral blood mononuclear cells and performed real-time (RT)-PCR to measure mRNA levels of chemokines, chemokine receptors, cytokines and T-reg markers. All the analyses were Bonferroni-corrected. The classical monocyte activation (M1) markers il6, ccl3 were significantly increased in BD as compared with both HC and SCZ patients (P=0.03 and P=0.002; P=0.024 and P=0.021, respectively), whereas markers of alternative (M2) monocyte activation ccl1, ccl22 and il10 were coherently decreased (controls: P=0.01, P=0.001 and P=0.09; SCZ subjects: P=0.02, P=0.05 and P=0.011, respectively). Concerning T-cell markers, BD patients had compared with HC downregulated ccr5 (P=0.02) and upregulated il4 (P=0.04) and compared with both healthy and SCZ individuals downregulated ccl2 (P=0.006 and P=0.003) and tgfβ (P=0.004 and P=0.007, respectively). No significant associations were found between any immune gene expression and clinical variables (prior hospitalizations, Brief Psychiatric Rating Scale, medications’ dosages and lifetime administration). Although some markers are expressed by different immune cell types, these findings suggest a coherent increased M1/decrease M2 signature in the peripheral blood of BD patients with potential Th1/Th2 shift. In contrast, all the explored immune marker levels were preserved in SCZ. Further larger studies are needed to investigate the relevance of inflammatory response in BD, trying to correlate it to psychopathology, treatment and outcome measures and, possibly, to brain connectivity.

24 March 2011 in European Archives of Psychiatry and Clinical Neuroscience
Verified
Journal Article
Open access
PDF file
GHGuillermo Horga
Guillermo Horga
JBJavier Bernacer
Javier Bernacer
NDNicola Dusi
Nicola Dusi
JEJonathan Entis
Jonathan Entis
KCKingwai Chu
Kingwai Chu
MBMonte S. Buchsbaum
Monte S. Buchsbaum
Ventricular enlargement is one of the most consistent abnormal structural brain findings in schizophrenia and has been used to infer brain shrinkage. However, whether ventricular enlargement is related to local overlying cortex and/or adjacent subcortical structures or whether it is related to brain volume change globally has not been assessed. We systematically assessed interrelations of ventricular volumes with gray and white matter volumes of 40 Brodmann areas (BAs), the thalamus and its medial dorsal nucleus and pulvinar, the internal capsule, caudate and putamen. We acquired structural MRI ( patients with schizophrenia (n = 64) and healthy controls (n = 56)) and diffusion tensor fractional anisotropy (FA) (untreated schizophrenia n = 19, controls n = 32). Volumes were assessed by manual tracing of central structures and a semi-automated parcellation of BAs. Patients with schizophrenia had increased ventricular size associated with decreased cortical gray matter volumes widely across the brain; a similar but less pronounced pattern was seen in normal controls; local correlations (e.g. temporal horn with temporal lobe volume) were not appreciably higher than non-local correlations (e.g. temporal horn with prefrontal volume). White matter regions adjacent to the ventricles similarly did not reveal strong regional relationships. FA and center of mass of the anterior limb of the internal capsule also appeared differentially influenced by ventricular volume but findings were similarly not regional. Taken together, these findings indicate that ventricular enlargement is globally interrelated with gray matter volume diminution but not directly correlated with volume loss in the immediately adjacent caudate, putamen, or internal capsule.

1 March 2016 in Frontiers in Psychiatry
Verified
Journal Article
Open access
PDF file
MBMarcella BELLANI
Marcella BELLANI
FBFilippo Boschello
Filippo Boschello
Giuseppe DelvecchioGiuseppe Delvecchio
Giuseppe Delvecchio
NDNicola Dusi
Nicola Dusi
CACarlo Alfredo Altamura
Carlo Alfredo Altamura
PBPaolo Brambilla
Paolo Brambilla
Bipolar disorder (BD) is a major psychiatric illness with a chronic recurrent course, ranked among the worldwide leading disabling diseases. Its pathophysiology is still not completely understood, and findings are still inconclusive, though a great interest on the topic has been constantly raised by magnetic resonance imaging (MRI), genetic and neuropathological studies. In recent years, diffusion tensor imaging (DTI) investigations have prompted interest in the key role of White Matter (WM) abnormalities in BD. In this report we summarized and commented recent findings from DTI studies in BD, reporting fractional anisotropy (FA) as putative measure of WM integrity, as well as recent data from neuropathological studies focusing on oligodendrocyte involvement in WM alterations in BD. DTI research indicates that BD is most commonly associated with a WM disruption within the fronto-limbic network, which may be accompanied by other WM changes spread throughout temporal and parietal regions. Neuropathological studies, mainly focused on the fronto-limbic network, have repeatedly shown a loss of oligodendrocyte cell count underlying WM alterations, although an increased oligodendrocyte density has been also documented suggesting a putative role in remyelination processes for oligodendrocytes in BD. According to our review, a greater integration between DTI and morphological findings is needed in order to elucidate processes affecting WM, either glial loss or myelin plasticity, on the basis of a more targeted research in BD.

9 October 2017 in Schizophrenia Bulletin
Verified
Journal Article
Open access
PDF file
VBValentina Baglivo
Valentina Baglivo
BCBo Cao
Bo Cao
BMBenson Mwangi
Benson Mwangi
MBMarcella BELLANI
Marcella BELLANI
Cinzia PerliniCinzia Perlini
Cinzia Perlini
GGGET UP Group
GET UP Group
Hippocampal abnormalities have been largely reported in patients with schizophrenia and bipolar disorder, and are considered to be involved in the pathophysiology of the psychosis. The hippocampus consists of several subfields but it remains unclear their involvement in the early stages of psychosis. The aim of this study was to investigate volumetric alterations in hippocampal subfields in patients at the first-episode psychosis (FEP). Magnetic resonance imaging (MRI) data were collected in 134 subjects (58 FEP patients; 76 healthy controls [HC]). A novel automated hippocampal segmentation algorithm was used to segment the hippocampal subfields, based on an atlas constructed from ultra-high resolution imaging on ex vivo hippocampal tissue. The general linear model was used to investigate volume differences between FEP patients and HC, with age, gender and total intracranial volume as covariates. We found significantly lower volumes of bilateral CA1, CA4, and granule cell layer (GCL), and of left CA3, and left molecular layer (ML) in FEP patients compared to HC. Only the volumes of the left hippocampus and its subfields were significantly lower in FEP than HC at the False Discovery Rate (FDR) of 0.1. No correlation was found between hippocampal subfield volume and duration of illness, age of onset, duration of medication, and Positive and Negative Syndrome Scale (PANSS). We report abnormally low volumes of left hippocampal subfields in patients with FEP, sustaining its role as a putative neural marker of psychosis onset.